Total Payments
$2,182
2024 Payments
$157.28
Companies
24
Transactions
108
Medicare Patients
3,313
Medicare Billing
$567,900
Payment Breakdown by Category
Food & Beverage$2,051 (94.0%)
Education$131.17 (6.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,051 | 98 | 94.0% |
| Education | $131.17 | 10 | 6.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Organogenesis Inc. | $270.17 | 1 | $0 (2023) |
| Smith+Nephew, Inc. | $199.37 | 5 | $0 (2024) |
| Gilead Sciences, Inc. | $193.05 | 12 | $0 (2021) |
| ViiV Healthcare Company | $192.93 | 12 | $0 (2020) |
| Merck Sharp & Dohme Corporation | $157.84 | 13 | $0 (2019) |
| KCI USA, Inc. | $152.07 | 2 | $0 (2020) |
| Melinta Therapeutics, LLC | $143.11 | 9 | $0 (2024) |
| Theravance Biopharma Inc. | $129.57 | 10 | $0 (2017) |
| Insmed, Inc. | $120.26 | 8 | $0 (2023) |
| Janssen Biotech, Inc. | $94.44 | 5 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $157.28 | 3 | Smith+Nephew, Inc. ($138.97) |
| 2023 | $331.00 | 4 | Organogenesis Inc. ($270.17) |
| 2022 | $64.98 | 4 | Shionogi Inc ($21.95) |
| 2021 | $134.52 | 8 | Gilead Sciences, Inc. ($73.62) |
| 2020 | $229.10 | 13 | Paratek Pharmaceuticals, Inc. ($63.75) |
| 2019 | $560.37 | 35 | Merck Sharp & Dohme Corporation ($111.23) |
| 2018 | $433.95 | 21 | KCI USA, Inc ($126.72) |
| 2017 | $270.85 | 20 | Theravance Biopharma Inc. ($129.57) |
All Payment Transactions
108 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/07/2024 | Smith+Nephew, Inc. | COLLAGENASE SANTYL (Drug) | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: Pharma Products | ||||||
| 04/24/2024 | Smith+Nephew, Inc. | GRAFIX PL (Medical Supply), STRAVIX | Food and Beverage | In-kind items and services | $118.43 | General |
| Category: Other Advanced Wound Management | ||||||
| 02/20/2024 | Melinta Therapeutics, LLC | Rezzayo (Drug), Kimyrsa | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: ANTIFUNGALS | ||||||
| 11/04/2023 | Smith+Nephew, Inc. | REGRANEX (Drug) | Food and Beverage | In-kind items and services | $27.27 | General |
| Category: Pharma Products | ||||||
| 10/04/2023 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: Respiratory | ||||||
| 05/24/2023 | Organogenesis Inc. | Puraply (Medical Supply) | Food and Beverage | Cash or cash equivalent | $270.17 | General |
| Category: Wound Care | ||||||
| 01/04/2023 | Smith+Nephew, Inc. | REGRANEX (Drug), COLLAGENASE SANTYL | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Pharma Products | ||||||
| 12/09/2022 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $21.95 | General |
| Category: Infections and Infectious Diseases | ||||||
| 10/12/2022 | ABBVIE INC. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $12.36 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/07/2022 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $12.54 | General |
| Category: Respiratory | ||||||
| 02/17/2022 | Smith+Nephew, Inc. | COLLAGENASE SANTYL (Drug) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: Pharma Products | ||||||
| 08/25/2021 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $21.19 | General |
| 08/17/2021 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.60 | General |
| 07/30/2021 | AbbVie Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $11.85 | General |
| Category: ANTI-INFECTIVE | ||||||
| 06/24/2021 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $13.53 | General |
| 05/12/2021 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $23.58 | General |
| Category: Infections and Infectious Diseases | ||||||
| 05/12/2021 | Shionogi Inc | Fetroja (Drug) | Education | In-kind items and services | $13.20 | General |
| Category: Infections and Infectious Diseases | ||||||
| 05/12/2021 | Shionogi Inc | Fetroja (Drug) | Education | In-kind items and services | $12.27 | General |
| Category: Infections and Infectious Diseases | ||||||
| 04/28/2021 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $21.30 | General |
| 10/28/2020 | Theratechnologies Inc. | EGRIFTA (Drug), TROGARZO | Food and Beverage | In-kind items and services | $12.68 | General |
| Category: HIV | ||||||
| 10/14/2020 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Education | In-kind items and services | $33.00 | General |
| Category: ANTIBIOTIC | ||||||
| 10/14/2020 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: ANTIBIOTIC | ||||||
| 10/07/2020 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $12.64 | General |
| Category: HIV | ||||||
| 09/09/2020 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $11.57 | General |
| Category: Respiratory | ||||||
| 08/26/2020 | La Jolla Pharmaceutical Company | XERAVA (Drug) | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: TETRACYCLINE CLASS ANTIBACTERIAL | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 663 | 1,647 | $232,816 | $100,833 |
| 2022 | 13 | 814 | 2,041 | $270,231 | $137,472 |
| 2021 | 9 | 892 | 2,365 | $296,040 | $166,784 |
| 2020 | 10 | 944 | 2,497 | $295,261 | $162,811 |
Total Patients
3,313
Total Services
8,550
Medicare Billing
$567,900
Procedure Codes
51
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 267 | 824 | $98,056 | $50,343 | 51.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 71 | 276 | $33,120 | $14,005 | 42.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 95 | 104 | $31,200 | $13,901 | 44.6% |
| 11042 | Removal of skin and tissue, 20.0 sq cm or less | Facility | 2023 | 37 | 123 | $32,964 | $5,662 | 17.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 55 | 82 | $9,840 | $5,373 | 54.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 29 | 48 | $8,160 | $3,676 | 45.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 20 | 28 | $4,760 | $2,534 | 53.2% |
| 97597 | Removal of tissue from wound, 20.0 sq cm or less | Facility | 2023 | 26 | 87 | $8,340 | $2,447 | 29.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 11 | 13 | $1,989 | $1,219 | 61.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 11 | 11 | $1,815 | $640.59 | 35.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2023 | 17 | 21 | $1,575 | $559.00 | 35.5% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 11 | 11 | $693.00 | $431.86 | 62.3% |
| 81003 | Automated urinalysis test | Office | 2023 | 13 | 19 | $304.00 | $41.80 | 13.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 313 | 1,171 | $135,597 | $68,888 | 50.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 143 | 157 | $45,200 | $26,029 | 57.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 58 | 179 | $26,715 | $16,348 | 61.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 61 | 171 | $20,110 | $8,223 | 40.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 51 | 73 | $8,610 | $4,649 | 54.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 24 | 34 | $5,710 | $3,223 | 56.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 17 | 32 | $5,377 | $2,480 | 46.1% |
| 97597 | Removal of tissue from wound, 20.0 sq cm or less | Facility | 2022 | 29 | 77 | $6,560 | $1,954 | 29.8% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 34 | 47 | $2,917 | $1,445 | 49.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 12 | 12 | $2,660 | $1,334 | 50.1% |
| 11042 | Removal of skin and tissue, 20.0 sq cm or less | Facility | 2022 | 12 | 21 | $5,628 | $992.25 | 17.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 11 | 11 | $1,780 | $880.34 | 49.5% |
About Dr. Johnny Huh, M.D
Dr. Johnny Huh, M.D is a Infectious Disease healthcare provider based in Westerville, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/26/2005. The National Provider Identifier (NPI) number assigned to this provider is 1962498972.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Johnny Huh, M.D has received a total of $2,182 in payments from pharmaceutical and medical device companies, with $157.28 received in 2024. These payments were reported across 108 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($2,051).
As a Medicare-enrolled provider, Huh has provided services to 3,313 Medicare beneficiaries, totaling 8,550 services with total Medicare billing of $567,900. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Ad
Practice Information
- Specialty Infectious Disease
- Location Westerville, OH
- Active Since 09/26/2005
- Last Updated 07/25/2018
- Taxonomy Code 207RI0200X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1962498972
Products in Payments
- Puraply (Medical Supply) $270.17
- VIBATIV (Drug) $129.57
- VAC VERAFLO (Device) $126.72
- Arikayce (Drug) $120.26
- GRAFIX PL (Medical Supply) $118.43
- Symtuza (Drug) $94.44
- DOVATO (Drug) $83.82
- Baxdela (Drug) $77.91
- Fetroja (Drug) $71.00
- ISENTRESS (Drug) $65.79
- CRESEMBA (Drug) $65.00
- NUZYRA (Drug) $63.75
- JULUCA (Drug) $57.92
- BEVYXXA (Drug) $52.32
- TRIUMEQ (Drug) $51.19
- TROGARZO (Drug) $47.02
- ZERBAXA (Drug) $46.50
- REGRANEX (Drug) $42.27
- AVYCAZ (Drug) $40.71
- COLLAGENASE SANTYL (Drug) $38.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Westerville
Steven Bobula, Md, MD
Infectious Disease — Payments: $48,979
Infectious Disease $48,979
Jane Emerick, M.d, M.D
Infectious Disease — Payments: $5,479
Infectious Disease $5,479
Dr. Sunil Bhat, Md, MD
Infectious Disease — Payments: $2,897
Infectious Disease $2,897
Timothy Anderson, Md, MD
Infectious Disease — Payments: $1,491
Infectious Disease $1,491
Wael Haidar, Md, MD
Infectious Disease — Payments: $340.27
Infectious Disease $340.27